Posaconazole

被引：36

作者：

Kauffman, Carol A.

Malani, Anuray N.

Easley, Chris

Kirkpatrick, Peter

机构：

[1] Univ Michigan, Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI 48105 USA

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2007年 / 6卷 / 03期

关键词：

D O I：

10.1038/nrd2270

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Posaconazole (Noxafil; Schering-Plough), a triazole antifungal drug, was approved by the US FDA in September 2006 for the prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections owing to being severely immunocompromised.

引用

页码：183 / 184

页数：2

共 14 条

[1] Refractory coccidioidomycosis treated with posaconazole [J].

Anstead, GM ;

Corcoran, G ;

Lewis, J ;

Berg, D ;

Graybill, JR .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (12) :1770-1776

[2] Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5] [J].

Bennett, F ;

Saksena, AK ;

Lovey, RG ;

Liu, YT ;

Patel, NM ;

Pinto, P ;

Pike, R ;

Jao, E ;

Girijavallabhan, VM ;

Ganguly, AK ;

Loebenberg, D ;

Wang, HY ;

Cacciapuoti, A ;

Moss, E ;

Menzel, F ;

Hare, RS ;

Nomeir, A .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) :186-190

[3] Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].

Cornely, Oliver A. ;

Maertens, Johan ;

Winston, Drew J. ;

Perfect, John ;

Ullmann, Andrew J. ;

Walsh, Thomas J. ;

Helfgott, David ;

Holowiecki, Jerzy ;

Stockelberg, Dick ;

Goh, Yeow-Tee ;

Petrini, Mario ;

Hardalo, Cathy ;

Suresh, Ramachandran ;

Angulo-Gonzalez, David .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359

[4] Posaconazole as salvage therapy for zygomycosis [J].

Greenberg, RN ;

Mullane, K ;

van Burik, JAH ;

Raad, I ;

Abzug, MJ ;

Anstead, G ;

Herbrecht, R ;

Langston, A ;

Marr, KA ;

Schiller, G ;

Schuster, M ;

Wingard, JR ;

Gonzalez, CE ;

Revankar, SG ;

Corcoran, G ;

Kryscio, RJ ;

Hare, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :126-133

[5] Voriconazole: A new triazole antifungal agent [J].

Johnson, LB ;

Kauffman, CA .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :630-637

[6] Zygomycosis: Reemergence of an old pathogen [J].

Kauffman, CA .

CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) :588-590

[7] Clinical efficacy of new antifungal agents [J].

Kauffman, Carol A. .

CURRENT OPINION IN MICROBIOLOGY, 2006, 9 (05) :483-488

[8] Antifungal agents: mechanisms of action [J].

Odds, FC ;

Brown, AJP ;

Gow, NAR .

TRENDS IN MICROBIOLOGY, 2003, 11 (06) :272-279

[9] Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions [J].

Raad, II ;

Hachem, RY ;

Herbrecht, R ;

Graybill, JR ;

Hare, R ;

Corcoran, G ;

Kontoyiannis, DP .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (10) :1398-1403

[10] Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers [J].

Sansone-Parsons, A ;

Krishna, G ;

Calzetta, A ;

Wexler, D ;

Kantesaria, B ;

Rosenberg, MA ;

Saltzman, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) :1881-1883

← 1 2 →